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a b s t r a c t
Perﬂuoroalkyl substances (PFASs) can interferewithmale reproductive function, but evidence in humans
is limited. Sixhundred four fertilemen (199 fromGreenland, 197 fromPolandand208 fromUkraine)were
enrolled in the study. We measured four PFASs in serum (PFOS, PFOA, PFNA and PFHxS) and concurrent
DNA damage in spermatozoa by sperm chromatin structure assay (SCSA) and in situ terminal deoxynu-
cleotidyl transferase dUTP nick-end labeling (TUNEL) assay, apoptotic markers in semen (Fas-receptor
and Bcl-xL), and reproductive hormones in serum. No association between PFASs and SCSA, apoptotic
markers or reproductive hormones emerged.Weobserved a slight increase in SHBGandTUNEL-positivityFOS
FOA
NA fragmentation index
perm chromatin structure assay
UNEL assay
as receptor
cl-xL
with increased PFOA exposure in men from Greenland. Thus, consistent evidence that PFAS exposure
interferes with sperm DNA fragmentation, apoptosis or reproductive hormones was not found.
© 2012 Elsevier Inc. All rights reserved.. Background
Perﬂuoroalkyl substances (PFSAs) are man-made surfactants
idely used in consumer and industrial products due to theirwater
nd lipid resistantproperties [1]. Theyare identiﬁedas global pollu-
ants and are suggested to pose health risks to humans and wildlife
1,2]. Of the PFASs, perﬂuorooctane sulfonate (PFOS) is found at the
ighest concentrations in humans as well as in the environment,
ollowed by perﬂuorooctanoic acid (PFOA) [3,4]. In Europe, median
erum concentrations in the adult non-occupationally exposed
opulation spans from 8 to 62ng/mL for PFOS [5] and from 0.5
o 40ng/mL for PFOA [6]. Human half-lives have been estimated in
∗ Corresponding author at: Department of Occupational and Environmental
edicine, BispebjergHospital, University Hospital of Copenhagen, Bispebjerg Bakke
3, 2400 Copenhagen NV, Denmark, Tel.: +45 3531 3777, fax: +45 3531 6070.
E-mail address: ispe0002@bbh.regionh.dk (I.O. Specht).
890-6238/$ – see front matter © 2012 Elsevier Inc. All rights reserved.
oi:10.1016/j.reprotox.2012.02.008geometric means to 4.8 (95% CI: 4.0;5.8) and 3.5 (95% CI: 3.0;4.1)
years, respectively [7].
PFASs bind to blood proteins and accumulatemainly in liver and
bile [6]. Animal studies demonstrate immunotoxicity, hepatotoxic-
ity and developmental toxicity of these compounds [1], in addition
to adverse reproductive effects. Thus decreased testosterone and
increased estradiol serum levels were seen in male rats follow-
ing administration of PFASs [8,9]. In mice, a recent study found
reduced serum concentrations of testosterone and reduced epi-
didymal sperm counts after daily exposure to 10mg PFOS/kg for
21 days, but not to 5 and 1mg PFOS/kg/day [10]. Moreover, expres-
sion of testicular receptors for gonadotrophin, growth hormone,
and insulin-like growth factor 1 was considerably reduced in mice
exposed daily to 10 or 5mg PFOS/kg [10]. Mouse serum concentra-
tionswere approximately 30–300 folds higher than expected in the
general humanpopulation; theseﬁndingsmight therefore not be of
direct relevance for human toxicity. Moreover, two-generation rat
studies did not observe changed mating or fertility after exposure
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o 3.2mg PFOS/kg/day and 30mg PFOA/kg/day [11,12]. Apoptosis
n testicular cell populations possibly arise secondarily to effect on
ale reproductive hormones, as testosterone and gonadotrophin
ithdrawal from the testis have been shown to increase germ cell
poptosis in rats [3]. In a study ofmale rats exposed to perﬂuorodo-
ecanoic acid (PFDoA) testosterone was markedly decreased with
eydig, Sertoli and germ cells showing apoptotic features including
ondensed chromatin after doses of 5 or 10mg PFDoA/kg/day [9].
poptosis of spermatogenic cells have also been observed in rats
xposed to 5mgkg/day of perﬂuorononanoic acid (PFNA), proba-
ly associated with the Fas receptor-dependent apoptotic pathway
13]. DNA strand breaks in the spermatozoa are suggested to be a
ign of sperm apoptosis [14]. In vitro, PFOA have been observed to
nduce DNA damage, measured as DNA strand breaks, and oxida-
ive stress in HepG2 cells and Vero cells [15,16]. However, a recent
tudy found no statistically signiﬁcant increase in oxidative DNA
amage in rat testicular cells studied in vitro by the comet assay
fter exposure to 100M or 300M of four PFASs (PFOA, PFNA,
:2 FTOH and 6:2 FTOH) [17].
A study of 256 men presenting at a clinic for fertility assess-
ent found no adverse associations between plasma and seminal
oncentrations of PFOS and PFOA on volume, sperm concentration,
ercent motility, swim-up motility and concentration or direc-
ional motility [18]. However, a Danish study of 105 young men
rom the general population found a higher proportion of mor-
hologically abnormal spermatozoa in men with higher levels of
ombined PFOS and PFOA [19], which may reﬂect higher levels of
NA damage in the spermatozoa [20,21].
DNA strand breaks can be detected by a variety of methods
ike the sperm chromatin structure assay (SCSA) [22] and the ter-
inal deoxunocleotidyl transferase-driven dUTP nick end labeling
TUNEL) assay [23]. The TUNEL assay measures apoptosis by pro-
iding a direct measure of DNA strand breaks of the spermatozoa
hereas SCSA indirectly reﬂects DNA damage through assessment
f chromatin susceptibility to acid denaturation. DNA damage of
he spermatozoa as measured by SCSA is a strong and reliable pre-
ictor of male fertility [24–26]. In a study of 229 male partners
f infertile couples, DNA fragmentation index correlated posi-
ivelyandsigniﬁcantlywith follicle stimulationhormone indicating
hat impaired spermatogenesis is associated with DNA damage
27]. Furthermore, sperm DNA damage is subject to less inter-
ndividual variation over time than sperm concentration [22,28] To
ur knowledge, no epidemiologic studies have investigated sperm
NA damage or apoptotic markers in human spermatozoa in rela-
ion to environmental PFAS exposure. The aim of this study was to
nvestigate the reproductive toxicity of PFASs by examining DNA
ragmentation and apoptotic markers of spermatozoa in a large
roup of fertile men. Since some experimental studies indicated
hanges in testosterone levels as mediators of association between
FAS exposure and sperm DNA integrity, we also assessed serum
evels of reproductive hormones.
. Materials and methods
.1. Study population
In the present study male partners of pregnant women were enrolled until at
otal of approximately 200 men had provided semen samples in each region [29].
n the original study altogether 3833 pregnant women and their male partners
ere encouraged to participate when presenting at the ﬁrst antenatal care visit
t one of three locations: (1) local hospitals in 19 cities and settlements throughout
reenland, (2) a large central hospital in Warsaw, Poland, and (3) three hospitals
nd eight antenatal clinics in Kharkiv, Ukraine. In all countries, it was required that
oth partners were 18 years or more of age and born in the country of the study.
he participation rate among all couples who were asked to participate was 26%
640/2478) in Kharkiv, 68% (472/690) in Warsaw, and 90% (598/665) in Greenland
30]. In total 1710 pregnant women (45%) were included in the study.
The low participation rate in Kharkiv was a consequence of the recruitment
rocedure where contact between potential participants and the project team wasicology 33 (2012) 577–583
managed by approximately 30 medical doctors at the three hospitals and eight
antenatal clinics.With this largeorganizationahigh level of informationandencour-
agement to participate was not possible.
Male partners were interviewed regarding lifestyle, occupational and repro-
ductive history. The interview included questions regarding occupational factors,
urogenital disorders, abstinence and issues regarding delivery of a semen sample.
Information about smoking habits and diet (seafood intake, caffeinated drinks and
alcohol consumption) was obtained as well, but with reference to the period when
the couple tried to become pregnant. The questionnaires were translated to the
native language and back translated to English for correction of errors that occurred
during the translation process. All questionnaires were typed by hand twice to min-
imize errors during the typing process. If inconsistencies occurred between the two
sets of typing, the original data was consulted and the typed data was corrected.
The local ethical committees representing all participating populations
approved the study and all subjects signed an informed consent.
2.2. Collection of semen and blood samples
We collected semen and blood samples between May 2002 and February 2004
in 604 of the male spouses as described in [31].
Participants were instructed to collect a semen sample by masturbation at their
residence after at least two days of sexual abstinence, and the duration of sexual
abstinence was recorded. The sample was kept close to the body to maintain a
temperature close to 37 ◦C when transported to the laboratory immediately after
collection. Twonunc cryotubes (VWR International, Roskilde, Denmark)with 0.2mL
aliquots of undiluted raw semen, collected 30min after liquefaction, were pre-
pared from each semen sample, coded and directly transferred into a −80 ◦C freezer
for later assessment of DNA fragmentation and expression of apoptotic markers.
After liquefaction, semen samples were analyzed for motility and concentration
of spermatozoa, according to recommendations by the World Health Organization
[29]. Results of the conventional semen analysiswill be the subject of another paper.
Venous blood sampleswere collectedwithin 1week of semen collection, except
for 116 of the Greenlandic blood samples, which were collected up to 1 year in
advance. The blood samples were centrifuged immediately after collection and sera
were stored at −80 ◦C for later analysis [29].
2.3. Determination of perﬂuoroalkyl substances
All serum samples were analyses at the department of Occupational and Envi-
ronmental Medicine in Lund, Sweden. Analysis for PFHxS, PFOS, PFOA, PFNA, PFDA,
perﬂuoroundecanoic acid (PFUnDA) and perﬂuorododecanoic acid (PFDoDA) was
performed using liquid chromatography tandem mass spectrometry (LC–MS/MS).
Aliquots of 100L serum were added 25L of a water:acetonitrile (50:50) solu-
tion containing 13C- or 18O-labeled internal standards for all evaluated compounds
(Wellington Laboratories Inc., Ontario, Canada; supplementary data). The proteins
wereprecipitatedwith175L acetonitrile andvigorously shook for 30min. Samples
were thereafter centrifuged and analyzed using a LC (UFLCXR, SHIMADZU Corpo-
ration, Kyoto, Japan) connected to a hybrid triple quadrupole linear ion trap mass
spectrometer (QTRAP 5500, Applied Biosystems).
SRM transitions used in the analysis are described in supplementary data pub-
lished online. Reported results represent the average of two measurements from
the same sample worked-up and analyzed on different days. These results were
also used to calculate the reproducibility of the method, determined as the coefﬁ-
cient of variation (CV) of duplicate samples worked-up and analyzed on different
days. These data and the limits of detection (LOD) are also shown in supplementary
data.
In all sample batches, the quality of the measurements was controlled by ana-
lyzing chemical blanks and in-house quality control samples. The method will be
described in detail elsewhere.
In all sample batches, the quality of the measurements was controlled by ana-
lyzing chemical blanks and in-house quality control samples. The method will be
described in detail elsewhere. Samples below LOD were included in the analyses
by half the value reported from the mass spectrometer. PFDA, PFUnDA and PFDoDA
were not detected in 112, 357 and 409 samples respectively, and due to the high
prevalence of samples belowdetection limits, analysiswere not performed for these
compounds.
The analyses of PFOS and PFOA are part of the Round Robin inter-comparison
program (Professor Dr.med. Hans Drexler, Institute andOut-Patient Clinic for Occu-
pational, Social and Environmental Medicine, University of Erlangen-Nuremberg,
Germany) with results within the tolerance limits.
2.4. Determination of DNA fragmentation by sperm chromatin structure assay
(SCSA)
DNA damage was measured by SCSA following a strict and standardized proce-
dure described by Evenson et al. [22].
All coded frozen semen samples from the three study regions were shipped on
dry ice to the ﬂow cytometry facility of the Section of Toxicology and Biomedical
Sciences (ENEA Casaccia, Rome, Italy), for SCSA analysis. The percentage of sperm
with detectable DNA fragmentation index (%DFI) was analyzed using a ﬂow cyto-
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etric (FCM) techniquewhich identiﬁes the spermatozoawith abnormal chromatin
ackaging, envisioned by increased susceptibility to acid-induced DNA denatur-
tion in situ. Measurements were stopped when a total of 20,000 sperms had
een accumulated for each sample. Acridine orange staining distinguished between
enaturated (redﬂuorescence, single stranded) andnative (greenﬂuorescence, dou-
le stranded) DNA regions in sperm chromatin. %DFI was calculated from the DFI
requency histogram obtained from the ratio between the red and total (red plus
reen)ﬂuorescence intensityusingadedicatedsoftware (SCSASoft; SCSADiagnostic,
rookings, SD, USA) [22,29]. Flow cytometer set-up and calibration were standard-
zed using a reference semen sample as described in Spanò et al. [29]. Inter-day
CSA variability, evaluated after 216 ﬂow sessions and considering the coefﬁcients
f variation (CV) of the %DFI was 6.0%. In addition, 358 randomly chosen samples
50.6% of the total) weremeasured twice in independent FCM sessions. Results from
he two measurements were highly correlated (DFI, r=0.96).
Finally, the reliability and stability of SCSA measurements has also been chal-
enged by an external quality control study that were carried out within the
ramework of this project, based on the blind analysis of three aliquots from seven
ifferent donors not selected among the participants in this study. The median
nter-sample variability for %DFI, expressed as CV, was 1.5% [29].
.5. Determination of DNA fragmentation by in situ terminal deoxynucleotidyl
ransferase dUTP nick-end labeling (TUNEL) assay
All coded frozen semen samples from the three study regions were shipped
n dry ice to the ﬂow cytometry facility of Polytechnic University of March
Ancona, Italy) for TUNEL analysis. The presence of free 3′-OH termini in the DNA
s indicative of a strand break. This fragmentation is detectable using an appropri-
tely modiﬁed ﬂuorescent nucleotide in an enzymatic reaction driven by terminal
eoxynucleotidyl transferase. The TUNEL technique uses dUTP-FITC conjugated for
he ﬂuorescent labeling of free 3′-OH termini and is analyzed using ﬂow cytom-
try, as described in details in [32]. Measurements were stopped when a total of
0,000 spermatozoa had been accumulated for each sample. The intra-laboratory
V regarding the TUNEL assay performance was constantly under 5%
.6. Determination of sperm Fas and Bcl-xL positivity
As for the TUNEL assay, all coded frozen semen samples from the three study
egions were shipped on dry ice to the ﬂow cytometry facility of Polytechnic Uni-
ersity of March (Ancona, Italy) for Fas and Bcl-xL analysis. To detect pro- (Fas) and
nti- (Bcl-xL) apoptotic markers on spermatozoa, incubation with anti-Fas primary
onoclonal antibodies was followed by a goat anti-mouse IgG-FITC conjugated sec-
ndary antibodies treatment, an indirect immunoﬂuorescence. Whereas for Bcl-xL
ssessment, the primary monoclonal antibody anti-Bcl-xL was detected by a goat
nti-mouse IgG-PE conjugated.Details aredescribed indepthelsewhere [32]. 20,000
perm cells were analyzed using ﬂow cytometry. Two different control ejaculates,
tored frozen at −80 ◦C in the laboratory, were thawed and processed according
o the Bcl-xL and Fas protocol before starting every FCM run which ensured stan-
ardization and stability of the instruments. The intra-laboratory CV regarding the
poptotic markers was in the range from 6% for Fas and 9% for Bcl-xL [32].
The results are given as percent Fas- and Bcl-xL-positive sperm cells.
.7. Determination of reproductive hormones
Serum concentrations of follicle-stimulating hormone (FSH), luteinizing hor-
one (LH), and estradiolwere analyzedwith immunoﬂuorometric techniques using
he UniCel DxI 800 Beckman Access Immunoassay system (Chaska, MN, USA). The
ower limits of detection (LODs) for the assayswere 0.2 IU/L, 0.2 IU/L, and 8.0pmol/L,
espectively. The total assay coefﬁcients of variation were 2.9%, 2.6%, and 8.1%,
espectively. Serum testosterone levels were measured by means of a competitive
mmunoassay (Access; Beckman Coulter Inc., Fullerton, CA, USA) with an LOD of
.35nmol/L and a total assay CV of 2.8% at 2.9nmol/L and 3.2% at 8.1nmol/L. Sex
ormone-binding globulin (SHBG) concentrations were measured using a ﬂuoro-
mmunoassay (Immulite 2000; Diagnostic Products Corporation, Los Angeles, CA,
SA). The LOD was 0.02nmol/L. The total assay coefﬁcients of variation were 5.5%
nd 4.6%, respectively. Inhibin B levelswere assessed using a speciﬁc immunometric
ethod, with a detection limit of 15ng/L and intra-assay and total assay coefﬁ-
ients of variation <7%, as previously described [33,34]. All assays were performed
t Malmö University Hospital (Sweden) after completion of sample collection.
.8. Statistical analysis
General linear models (Proc GLM) were used to analyze uncorrected and
djusted associations, as well as trend analyses, between serum concentrations
f PFASs and sperm DNA damage, apoptotic markers and reproductive hormones,
espectively. The trend statistics were based on analysis of continuous outcome and
xposure variables. Serum levels of the four exposure PFASs (PFOS, PFOA, PFNA and
FHxS) were divided into tertiles in each of the three study regions, Greenland,
oland and Ukraine. The outcome variables, %DFI, TUNEL-positivity, Fas, Bcl-xL,
estosterone, estradiol, inhibin-B, FSH, LH and SHBG were analyzed on a continuous
cale.icology 33 (2012) 577–583 579
All analyseswere stratiﬁedby study region. In themultiple general linearmodels
we adjusted for known and possible confounders, namely, sexual abstinence period
[log(days)], age (years), bodymass index (BMI, kg/m2), caffeinateddrinks (cups/day),
cotinine in serum [log(ng/mL)], fever during the past three month (yes/no), self
reported genital infections (yes/no) and testicular disorders (yes/no), as well as for
spillage of semen sample (yes/no) [35]. Alcohol consumption was not included in
the analyses because these data were missing for 64% in Greenland, 14% in Poland
and 26% in Ukraine.
Furthermore, we examined interactive effects of PFOS (dichotomized by the
median) and the following covariates: age (dichotomized at age 35), smoking status
when wife became pregnant (yes/no), cotinine levels in serum (dichotomized at
the median), and PFOA (dichotomized by the median). The main effect, PFOS, was
multiplied with each the covariates mentioned above. The outcome variables (%DFI,
TUNEL-, Fas- or Bcl-xL-positivity) of the interaction analysis were on a continuous
scale. Interaction effects were only examined for PFOS because it was the PFAS with
the highest exposure level in the three study regions.
Correlations between the seven PFASs were examined by the non-parametric
method Spearman’s rank correlation.
Residuals were checked for normality and where appropriate, continuous
variables were transformed by natural logarithm: DFI (%), TUNEL-positivity (%),
Fas-positivity (%), Bcl-xL-positivity (%), testosterone, estradiol, inhibin-B, FSH, LH,
SHBG, sexual abstinence time, cotinine and PFASs. Mean, median, adjusted mean
and 95% conﬁdence interval (95% CI) for DFI, Fas and Bcl-xL were back transformed
for presentation in Tables 3–5.
Statistical analysis of the data was performed with SAS software, version 9.1 for
Windows (SAS Institute Inc., Cary, NC, USA).
3. Results
Demographic and semen characteristics of the 604 adult men
fromGreenland, Poland andUkrainewith complete data are shown
in Table 1. The number of missing values for Bcl-xL and Fas from
Poland (49.7% and 37.6%, respectively) and Ukraine (78.4% and
32.7%, respectively) were high due to accidental loss of samples
during shipment and insufﬁcient number of cells for analysis. In
Greenland, 27.6% Bcl-xL and 3.0% Fas samples were missing due
to insufﬁcient cell numbers. For reproductive hormone samples,
32% 41% and 0.1% were missing in Greenland, Poland and Ukraine,
respectively.
Serumconcentrations of the sevenmeasured PFASs differed sig-
niﬁcantly among regionswith the highest concentrations observed
inGreenland (Table 2). PFOS occurred at the highest concentrations
in all countries followed by PFOA. Serum levels of the individual
PFASs were highly and signiﬁcantly correlated, with correlation
coefﬁcients ranging from r=0.4 (PFUnDA and PFOA, p<0.001)
to r=0.9 (PFDoDA and PFUnDA, p<0.001) (data not shown). No
seasonal variations were observed for the PFASs. No signiﬁcant
interactions for PFOS and the covariates (age, smoking status, coti-
nine and PFOA) on DFI, TUNEL, Fas and Bcl-xL were revealed.
3.1. Sperm chromatin structure assay
An association of PFOS, PFOA, PFNA or PFHxS with sperm DNA
fragmentation was not found in any of the three regions in uncor-
rected analyses, and similar resultswere obtained after adjustment
for potentially confounding effects (results for PFOS and PFOA are
given in Tables 3 and 4, respectively).
3.2. TUNEL assay
Serum PFOA was associated with increased percentage TUNEL-
positive sperm cells in men from Greenland but only in the trend
analysis [uncorrectedp=0.077, uncorrected trendp=0.026andadj.
p=0.10, adj. trend p=0.033; adjusted means (95% CI) for %TUNEL-
positive sperm cells in each PFOA tertile: 12.3% (5.2;28.9), 14.8%
(6.1;35.9), 17.3% (7.2;41.32)]. No such associations were observed
in Poland or Ukraine, nor were PFOS, PFHxS and PFNA associated
with TUNEL-positivity.
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Table 1
Characteristics of the study populations.
Greenland (N=199) Poland (N=197) Ukraine (N=208)
n Percenta Mean Median Range n Percenta Mean Median Range n Percenta Mean Median Range
Population characteristics
Period of abstinence
(days)
199 5.3 3.0 0.5–240 152 7.7 4.0 0.1–90 208 3.9 3.0 0.5–11
Seafood intake (week) 190 2.1 1.8 0–7 178 1.2 1.0 0–6 NA NA NA NA
Age (years) 197 31.0 30.6 19–51 196 30.3 29.6 20–46 204 26.5 25.1 16–45
Body mass index (kg/m2) 197 26.1 25.5 12–58 194 25.8 25.4 19–38 205 24.2 24.0 18–36
Caffeinated drinks per
day
187 6.8 6.0 0.5–30 188 4.4 4.0 1–13 195 3.3 3.0 1–14
Cotinine (ng/mL) 196 165.1 143.5 0.3–570 190 39.9 0.31 0.3–446 205 153.5 119.7 0.3–799
Current smokers 198 72.7 196 27.2 206 66.7
>14 alcoholic drinks a
week
71 26.8 169 11.2 154 0.7
Mother smoked during
pregnancy
122 62.3 170 14.7 182 1.7
Fever the last three
month
196 13.3 195 8.7 203 9.9
Employed 153 85.9 91 87.4 156 76.4
Genital infectionb 199 82.4 197 5.1 208 4.9
Testicular disordersc 199 0.5 197 4.1 208 3.4
Semen parameters
DFI (%) 198 9.1 7.5 1–38 143 12.2 9.7 3–49 207 13.3 10.5 2–50
TUNEL positive (%) 198 4.5 2.9 0.3–45 134 15.2 13.1 0–80 133 9.3 6.7 0.02–50
Fas (%) 193 25.0 19.0 0–91 123 48.6 42.3 0–98 140 28.2 17.3 0–98
Bcl-xL (%) 144 26.5 10.7 0–97 99 18.1 9.3 0–90 45 66.0 75.5 0.2–99
Reproductive hormones
Testosterone (nmol/L) 135 14.8 14.2 3–27 116 13.1 12.7 5–24 207 18.0 17.7 6–37
Estradiol (pmol/L) 135 65.5 65.3 33–113 116 75.8 69.0 36–297 206 84.1 79.1 33–160
FSH (IU/L) 135 4.9 4.3 0–15 116 4.0 3.6 0.7–17 207 4.2 3.4 1–21
LH (IU/L) 135 4.4 4.1 1–13 116 4.1 3.7 1–9 207 4.2 4.0 1–13
Inhibin B (ng/L) 135 184.2 181.0 48–470 116 157.9 153.0 22–338 207 194.6 186 55–390
SHBG (nmol/L) 135 28.2 27.9 11–55 116 23.6 21.7 6–64 207 27.7 26.8 9–64
a Percent if the variable is dichotomous.
.
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Pb Genital infections: epididymitis, gonorrhea, Chlamydia or mumps in adulthood
c Testicular disorders: treatment for retracted testis, surgery for varicose veins, t
A: not analyzed
.3. Apoptotic markers
In all regions, the higher the PFOS serum concentration,
he higher were the percentage of sperm cells positive for the
ro-apoptotic marker Fas (Table 3). The trend was statistically sig-
iﬁcant for Polish men only (p trend=0.03), but the association
etween the tertile means were not signiﬁcant (Table 3), and an
verall analysis including all three regions did not reach statistical
igniﬁcance (data not shown). No other associations between PFOA
Table 4), PFNA and PFHxS and apoptotic markers were consistent
cross regions or in models within regions..4. Reproductive hormones
Serum concentrations of PFOA were associated with higher
HBG in Greenland and Poland, although this tendency was not
able 2
FAS serum concentrations in men from Greenland, Poland and Ukraine.a,b
PFAS (ng/mL) Greenland (N=199) Poland (N=197)
Mean Median Range %>LOD Mean Median
PFOS 51.9 44.7 12–161 100 18.6 18.5
PFOA 4.8 4.5 2–14 100 5.1 4.8
PFNA 2.3 1.4 0.5–12 100 1.3 1.2
PFHxS 2.8 2.2 1–21 100 1.2 1.2
PFDA 1.1 0.9 0.1–6 99 0.4 0.4
PFUnDA 1.7 1.3 0.2–13 94.4 0.3 0.3
PFDoDA 0.2 0.1 0.04–2 80.6 0.1 0.1
a Missing values: there were 3 missing values for each PFAS in Greenland, 7 for each PF
b The mean of PFOS, PFOA, PFNA, PFHXS, PFDA, PFUnDA and PFDoDA differs signiﬁcantestis or testis cancer.
signiﬁcant after adjustment in Greenland (Table 5). PFOS, PFNA
and PFHxS were not consistently related to SHBG concentrations
(datanot shown) andassociations betweenPFASs and testosterone,
estradiol and gonadootrophins were not consistent across regions
(data not shown).
4. Discussion
The large majority of previous studies of alterations in sperm
chromatin compareddata frompatients affectedby infertilityprob-
lems with a variety of control subjects. Overall, these studies
indicate correlation between sperm DNA integrity and human fer-
tility [13,36].Data in thepresentpaper represent, toourknowledge,
the ﬁrst study addressing effects of PFASs on sperm DNA fragmen-
tation and apoptotic markers in semen collected from spouses of
pregnant woman, representing all degrees of sub-fecundity except
Ukraine (N=208)
Range %>LOD Mean Median Range %>LOD
8–40 100 8.1 7.6 3–30 100
2–16 100 1.8 1.3 0.3–35 92.1
0.5–6 100 1.1 1.0 0.2–4 100
0.4–4 100 0.4 0.3 0.03–3 99.5
0.1–1 96.3 0.3 0.2 0.1–1 51.2
0.2–0.7 11.6 0.3 0.3 00.2–0.5 12.3
0.04–0.2 8.4 0.1 0.1 0.04–0.1 3.0
AS in Poland and 3 for each PFAS in Ukraine.
ly among regions (p<0.0001, ANOVA).
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Table 3
DNA fragmentation index (DFI), Fas and Bcl-xL according to PFOS in serum by study populations.a
PFOS (ng/mL) DFI (%) Fas (%) Bcl-xL (%)
Tertiles n Median Mean Adj. meanb (95% CI) n Median Mean Adj. meanb (95% CI) n Median Mean Adj. meanb (95% CI)
Greenland
0.1–35.5 66 7.1 8.4 11.6 (6.2;21.7) 65 18.8 22.7 16.7 (5.8;48.2) 45 11.3 25.9 10.3 (5.2;20.5)
35.5–62.6 66 7.2 8.9 11.7 (6.1;22.3) 64 21.2 26.4 22.9 (7.7;68.4) 51 15.0 31.0 14.9 (7.7;28.9)
62.6–160.6 66 8.4 10.0 13.2 (6.9;25.1) 64 19.4 25.9 23.4 (7.9;69.3) 48 8.5 22.3 10.6 (5.7;9.7)
Poland
0.1–14.9 49 9.8 12.2 14.4 (8.5;20.4) 38 31.1 44.1 13.7c (5.5;34.2) 31 12.2 19.7 50.4 (8.4;301.9)
14.9–20.8 52 10.3 12.0 12.1 (8.7;16.9) 37 50.5 50.6 15.5 (6.3;38.3) 36 10.1 19.4 55.7 (13.5;229.4)
20.8–40.2 42 8.4 12.3 13.7 (10.0;18.7) 38 49.7 50.6 19.3 (8.2;45.9) 32 7.8 14.9 39.8 (7.6;208.3)
Ukraine
0.1–5.9 67 11.5 14.0 14.4 (10.1;20.4) 47 17.6 28.1 13.7 (5.5;38.3) 12 74.8 64.6 50.4 (8.4;301.9)
5.9–8.5 69 8.8 12.5 12.1 (8.7;16.9) 45 14.8 25.8 15.5 (6.3;38.3) 17 88.0 70.0 55.7 (13.5;229.4)
8.5–29.9 69 11.8 13.6 13.7 (10.0;18.7) 46 20.3 30.8 19.4 (8.2;45.9) 14 75.4 62.3 39.8 (7.6;208.3)
CI = conﬁdence interval.
a Non of the analyzed differences were statistical signiﬁcant.
b Adjusted for age, body mass index, caffeinated drinks, cotinine, fever, spillage, abstinence time, genital infections and testicular disorders.
c p-Trend=0.03 for adjusted Fas means according to PFOS in Polish men.
Table 4
DNA fragmentation index (DFI), Fas and Bcl-xL according to PFOA in serum by study populations.a
PFOA (ng/mL) DFI (%) Fas (%) Bcl-xL (%)
Tertiles n Median Mean Adj. meanb (95% CI) n Median Mean Adj. meanb (95% CI) n Median Mean Adj. meanb (95% CI)
Greenland
1.5–4.2 64 6.9 8.6 11.6 (6.2;21.6) 63 18.5 23.7 17.9 (6.1;52.2) 44 11.2 22.6 11.5 (5.7;23.2)
4.2–5.5 66 7.0 8.9 11.9 (6.2;22.5) 63 18.8 24.9 19.8 (6.6;59.6) 48 6.5 25.7 10.3 (5.2;20.6)
5.3–13.7 65 8.6 9.8 12.9 (6.8;24.4) 64 23.0 26.6 20.7 (7.0;61.5) 51 10.9 29.4 12.5 (6.9;22.8)
Poland
1.5–4.2 52 8.5 12.1 15.4 (8.9;26.5) 41 50.6 50.6 33.8 (11.2;102.1) 41 50.6 50.6 2.1 (0.4;10.9)
4.2–5.7 40 9.6 12.3 15.4 (8.9;26.8) 35 40.5 45.7 35.8 (11.9;109.1) 35 40.5 45.7 1.9 (0.4;9.1)
5.7–16.0 50 10.3 12.1 14.7 (7.9;27.3) 46 44.7 49.7 43.4 (12.6;149.2) 46 44.7 49.7 2.0 (0.3;11.8)
Ukraine
0.3–1.0 68 9.7 13.4 13.4 (9.6;18.8) 48 22.0 34.2 18.5 (7.6;45.4) 14 57.0 58.1 36.1 (7.0;84.5)
1.0–1.6 69 10.2 12.9 12.9 (9.3;17.9) 44 16.4 26.9 12.7 (5.0;32.2) 15 91.5 77.7 86.7 (18.4;407.8)
1.6–35.0 68 11.9 13.7 13.6 (9.8;18.9) 47 13.1 22.5 18.5 (7.5;45.6) 16 81.7 66.0 50.0 (13.4;187.0)
C
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CI = conﬁdence interval.
a Non of the analyzed differences were statistical signiﬁcant.
b Adjusted for age, body mass index, caffeinated drinks, cotinine, fever, spillage, a
terility. The results are reassuring with no indications of adverse
ffects, except for a slight increase in %TUNEL positive sperm cells
nd SHBG associated with PFOA exposure in men from Greenland.
A previous investigation of relationships between serum levels
f PFASs and semen quality in Danish young men (median age, 19
ears) from the general population, found that a combination of
able 5
ex-hormone binding globulin (SHBG) according to PFOA in serum by study populations
PFOA (ng/mL) SHBG (nmol/L)
Tertiles n Median Mean pcrude
Greenland
1.5–4.2 44 24.3 25.3 0.03
4.2–5.5 45 30.1 29.4
5.3–13.7 45 29.7 30.6
Poland
1.5–4.2 43 19.0 21.5 0.19
4.2–5.7 33 22.9 25.4
5.7–16.0 40 23.4 24.5
Ukraine
0.3–1.0 69 25.9 27.6 0.93
1.0–1.6 69 27.6 28.0
1.6–35.0 69 26.5 27.5
Across regions
0.3–2.4 188 26.9 27.8 0.09
2.4–4.7 144 23.5 25.4
4.7–35.0 125 25.6 27.2
I = conﬁdence interval.
a Adjusted for age, body mass index, caffeinated drinks, cotinine, fever, spillage, abstinence time, genital infections and testicular disorders.
high PFOS and PFOA levels were associated with lower numbers of
normal sperm cells [19].Associations of environmental chemical exposures like poly-
chlorinated biphenyls and dichlorodiphenyldichloroethylene with
DNA fragmentation in fertile populations have previously been
identiﬁedbySCSAandTUNELassay [29,37], but in thepresent study
and across regions.
ptrend Adj. meana (95% CI) padj. ptrend
0.01 30.5 (22.3;41.7) 0.07 0.08
35.6 (25.6;49.3)
34.7 (25.2;47.7)
0.12 15.0 (10.7;21.0) 0.003 0.07
21.5 (15.3;30.2)
17.8 (12.3;25.8)
0.74 26.8 (22.2;32.3) 0.77 0.82
27.6 (32.0;33.1)
26.4 (22.0;31.7)
0.14 24.7 (21.3;28.6) 0.06 0.39
24.2 (21.2;27.7)
27.0 (23.6;31.0)
ence time, genital infections and testicular disorders.
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reenlandic, Polish and Ukrainian populations seemed unaffected
r only marginally affected by the present level of PFAS exposure.
In rats, perﬂuorononanoic acid (PFNA) has been observed
o induce sperm cell apoptosis at a dose level of 3 and 5mg
FNA/kg/day, examined by changes in Fas mRNA expression levels
n testis [13]. In our study, higher PFOS serum concentrations were
ssociated with higher percentage of sperm cells positive for the
ro-apoptotic marker Fas, but only for Polish men (p trend=0.03)
hereas no other associations between PFASs and apoptotic mark-
rs were consistent across regions or in different models within
egions, which might be because of the low exposure levels.
Some animal studies of PFAS exposure and male fertility report
ncreased estradiol and decreased serum testosterone in male
ats and mice as well as changes in testicular cell populations
1,10]. However, another study of rats orally exposed up to 30mg
FOA/kg/day found no evidence of altered testicular structure and
unction [12]. We found no consistent associations between PFOS
nd reproductive hormones except SHBG. Although decreased
estosterone levels in testis can increase germ cell apoptosis in
ats [38], the levels of PFASs might be too low to causally affect
estosterone production in the adult human testis. Some epidemi-
logical studies have addressed male reproductive toxicity of PFOS
nd PFOA and reported no signiﬁcant associations with estradiol
nd testosterone levels [18,19,39]. One US occupational study of
82 men employed at a polymer plant in West Virginia reported a
igniﬁcant association between PFOA (median serum levels were
94ng/mL) and serum estradiol and testosterone in linear regres-
ion models (regression coefﬁcients =22.3pmol/L and 0.6nmol/L,
espectively) [40]. Anoccupational studyofworkers in a PFOAplant
lso observed signiﬁcant and positive association between serum
stradiol in men with the highest PFOA levels (>30000ng/mL),
owever this observation was likely confounded by body mass
ndex [39]. A study by Raymer et al. found positive correlation of
H with plasma PFOS and PFOA, but no associations with seminal
arameters were observed [18]. Finally, a recent study of age of
uberty found a relationship of reduced odds of having reached
uberty, using total testosterone as an puberty indicator, with
ncreased serum levels of PFOS in boys [41]. This indicates later
nset of puberty or postponement of the testosterone surge in
oys when highly exposed to PFOS (>19.4ng/mL), but the asso-
iation did not prove signiﬁcant for PFOA [41] We observed a
light increase in SHBG with increased PFOA exposure in men from
reenland. SHBG is produced in the liver andPFOAhavebeen found
o be hepatotoxic in animal studies [1]. We speculate that high
oncentrations of PFOA may activate the peroxisome proliferator-
ctivated receptor  (PPAR) that reduces lipids in the liver and
nsulin in the blood [42] and thereby up-regulates SHBG. However,
his does not ﬁt observations of decreased testosterone after PFAS
xposure in rodents [2]. Furthermore, two cross-sectional stud-
es of chemical workers with serum PFOA concentrations between
and 80,000ng/mL (n=111) and between 0 and 115,000ng/mL
n=80), respectively found no association between PFOA exposure
nd SHBG despite of higher exposure levels than observed in the
resent study [39].
The median PFOS level in the Greenlandic study population
45ng/mL) was almost twice as high as in Danish (25ng/mL) and
merican populations (21ng/mL) [19,43], but at the same time the
reenlandic population considered in the present study is charac-
erized by the lowest level of DNA fragmentation detected by SCSA
29,32]. In comparison, the highest level of DNA fragmentation was
n the Ukrainian study populations, which had the lowest serum
oncentrations of PFASs. Overall, the %DNA fragmentation levels
n the two European countries and in Greenland are in range with
evels observed in other European populations [44,45].
The analysis of serum concentrations of PFASs, reproduc-
ive hormones, SCSA and TUNEL were analyzed in the sameicology 33 (2012) 577–583
laboratories for all three study regions. Collection of semen and
blood samples was done according to the same procedures in
the three countries. The substantial variations in PFAS levels,
%DFI, %TUNEL-positive and apoptoticmarkers between regions can
therefore not be due to inter-laboratory variations or variations
in procedures but are most likely explained by other factors like
genetics, disease patterns, different food habits or unknown con-
comitant exposures.
Cross sectional studies of semen quality suffer often of low par-
ticipation rates which may bias the internal validity of a study. In
occupational semen studies, sub-fertility seems to be a stronger
motivation for participation among referents than among exposed
workers, who may have an interest to have potential harmful
exposures documented [31]. Such a differential selection may,
however, be less important in this environmental study where
the participants may know little or nothing about their individ-
ual exposure level. Thus, low participation rates are not expected
to bias the relation between exposure and semen characteris-
tics [31]. Furthermore, selection bias is unlikely since the length
of time to pregnancy did not differ among couples where men
provided a semen sample in comparison with couples where
men declined to deliver semen [32]. The participation rate was
low in Ukraine (26%) due to the recruitment procedure. Demo-
graphic and reproductive information was obtained from a sample
of 605 of those Ukrainian women that declined participation
in the study. Only average age was slightly lower among non-
participating women [22.8 (SD 2.4) versus 24.9 (SD 2.8) years]
[30].
In Greenland 116 of the 199 blood samples were collected
approximately a year before the semen samples. Since half-lives
for PFASs in humans are in the range of years [7] and no seasonal
variations in PFAS exposure was observed, bias because of skewed
sampling is unlikely.
5. Conclusion
Our data do not suggest that exposure to PFOS, PFOA, PFHxS and
PFNA in men of pregnant women is associated with DNA damage
or apoptosis in sperm cells or changes in serum levels of reproduc-
tive hormones (estrogen, testosterone, FSH, LH). We did observe a
slight increase in SHBG and TUNEL-positivity with increased PFOA
exposure in men from Greenland, though not consistent or in line
with previous study results.
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